Ask AI

Leukemias

Share

Program Content

Activities

  • PulseCast Leukemias ASH 2025
    PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2025

Activities

SAVE Trial
SAVE: Phase I/II Study of Oral Revumenib Plus Decitabine/Cedazuridine and Venetoclax in Cohort of Patients with Newly Diagnosed AML
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2025

ASC2ESCALATE
ASC2ESCALATE: Asciminib in Patients With Chronic-Phase CML After 1 Prior TKI
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 11, 2025

VICEROY
VICEROY: Venetoclax + Azacitidine + Gilteritinib in Patients With ND FLT3-Mutated AML Ineligible for Intensive Induction Chemotherapy
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

PARADIGM
PARADIGM: Randomized Phase II Trial of Azacitidine + Venetoclax vs Conventional Intensive Chemotherapy for Fit Patients With Newly Diagnosed AML
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

FASCINATION
Phase II FASCINATION: 3-Yr Update of Asciminib + Conventional BCR::ABL1 Inhibitors in Newly Diagnosed CML
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2025

KOMET 007
KOMET-007: Phase Ib Study of Ziftomenib + Venetoclax/Azacitidine in Newly Diagnosed NPM1-Mutated Acute Myeloid Leukemia
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

Supporters

Supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.

AstraZeneca

BeOne Medicines

Genentech

Geron Corporation

Incyte

Johnson & Johnson

Lilly

Novartis Pharmaceuticals Corporation

Partners

Smart Patients

ProCE Banner